Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-4,817
Closed -$500K 4067
2023
Q3
$495K Buy
4,817
+2,665
+124% +$287K 0.05% 425
2023
Q2
$248K Sell
2,152
-870
-29% -$98.8K 0.03% 535
2023
Q1
$321K Sell
3,022
-21,036
-87% -$2.27M 0.03% 490
2022
Q4
$2.67M Sell
24,058
-31,376
-57% -$3.21M 0.23% 89
2022
Q3
$4.77M Buy
+55,434
New +$4.95M 0.33% 43
2022
Q2
Sell
-39,566
Closed -$3.51M 5415
2022
Q1
$3.25M Buy
39,566
+35,602
+898% +$2.81M 0.17% 122
2021
Q4
$303K Sell
3,964
-53,320
-93% -$4.25M 0.01% 1034
2021
Q3
$4.3M Buy
+57,284
New +$4.36M 0.19% 103
2020
Q4
Sell
-524
Closed -$40.1K 5250
2020
Q3
$41K Buy
+524
New +$41K ﹤0.01% 1923
2020
Q2
Sell
-5,240
Closed -$394K 4686
2020
Q1
$384K Buy
5,240
+1,223
+30% +$96.1K 0.02% 654
2019
Q4
$348K Buy
4,017
+3,261
+431% +$268K 0.02% 589
2019
Q3
$60K Sell
756
-1,855
-71% -$149K 0.01% 1402
2019
Q2
$208K Sell
2,611
-2,456
-48% -$188K 0.02% 693
2019
Q1
$402K Buy
5,067
+2,201
+77% +$165K 0.04% 385
2018
Q4
$208K Sell
2,866
-10,346
-78% -$730K 0.02% 625
2018
Q3
$894K Buy
13,212
+7,441
+129% +$474K 0.06% 298
2018
Q2
$334K Buy
5,771
+5,748
+24,991% +$324K 0.03% 573
2018
Q1
$1K Sell
23
-8,128
-100% -$439K ﹤0.01% 4096
2017
Q4
$437K Sell
8,151
-332
-4% -$18.4K 0.02% 602
2017
Q3
$518K Sell
8,483
-23,192
-73% -$1.41M 0.02% 639
2017
Q2
$1.94M Buy
31,675
+19,613
+163% +$1.19M 0.07% 224
2017
Q1
$731K Sell
12,062
-23,778
-66% -$1.44M 0.03% 501
2016
Q4
$2.01M Buy
35,840
+880
+3% +$51.5K 0.07% 200
2016
Q3
$2.08M Sell
34,960
-78,656
-69% -$4.6M 0.09% 153
2016
Q2
$6.25M Buy
113,616
+103,267
+998% +$5.5M 0.32% 40
2016
Q1
$522K Buy
10,349
+6,904
+200% +$338K 0.03% 508
2015
Q4
$173K Buy
+3,445
New +$174K 0.01% 1305

Other funds holding MRK

Cutler Group's MRK Position: Q4 2023 in Review

Cutler Group sold out of Merck (MRK) in Q4 2023, closing a stake of 4,817 shares — an estimated $500K sold.

Cutler Group first reported a position in MRK in Q4 2015 and held it in 27 quarters. The position peaked at $6.25M in Q2 2016. 3,434 funds tracked by Wall St. Rank hold MRK as of Q4 2023.

  • Cutler Group reported no remaining Merck position as of Q4 2023 after selling out during the quarter.
  • Cutler Group sold 4,817 Merck shares in Q4 2023, an estimated $500K.
  • Cutler Group first reported a position in Merck in Q4 2015 and held it in 27 quarters.
  • Cutler Group's Merck position peaked at $6.25M in Q2 2016.
  • 3,434 funds tracked by Wall St. Rank held Merck as of Q4 2023.

Based on Cutler Group's 13F filing for Q4 2023, filed 18 Jan 2024.